Back
Revance Therapeutics Stock Price Chart
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
20
RVNC
Revance Therapeutics
Last Price:
5.75
Seasonality Move:
-5.59%
7 Day Trial
ALL ACCESS PASS
$
7
Hint at where the next big move in the market will be this month
Spot the next big move with this free book from a hedge fund manager- The current trend is moderately bearish and RVNC is experiencing slight selling pressure.
Revance Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.25 | Sell |
| 20-day SMA: | 6.45 | Sell |
| 50-day SMA: | 5.22 | Buy |
| 200-day SMA: | 5.04 | Buy |
| 8-day EMA: | 6.16 | Sell |
| 20-day EMA: | 6.17 | Sell |
| 50-day EMA: | 5.44 | Buy |
| 200-day EMA: | 6.58 | Sell |
Revance Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.2 | Buy |
| Relative Strength Index (14 RSI): | 44.27 | Sell |
| Chaikin Money Flow: | -1144763 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.24 - 6.72) | Sell |
| Bollinger Bands (100): | (2.6 - 5.68) | Buy |
Revance Therapeutics Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Revance Therapeutics Stock
Is Revance Therapeutics Stock a Buy?
- Revance Therapeutics share price is 5.85 while RVNC 8-day simple moving average is 6.25, which is a Sell signal.
- The stock price of RVNC is 5.85 while Revance Therapeutics 20-day SMA is 6.45, which makes it a Sell.
- Revance Therapeutics 50-day simple moving average is 5.22 while RVNC share price is 5.85, making it a Buy technically.
- RVNC stock price is 5.85 and Revance Therapeutics 200-day simple moving average is 5.04, creating a Buy signal.
RVNC Technical Analysis vs Fundamental Analysis
Sell
20
Revance Therapeutics (RVNC)
is a Sell
Is Revance Therapeutics a Buy or a Sell?
-
Revance Therapeutics stock is rated a Sell
The current Revance Therapeutics [RVNC] share price is $5.85. The Score for RVNC is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
Revance Therapeutics Stock Info
Market Cap:
609.46M
Price in USD:
5.85
Share Volume:
5.4M
Revance Therapeutics 52-Week Range
52-Week High:
13.12
52-Week Low:
2.30
Sell
20
Revance Therapeutics (RVNC)
is a Sell
Revance Therapeutics Share Price Forecast
-
What is the Revance Therapeutics stock price today?
The Revance Therapeutics stock price is 5.85 USD today. -
Will RVNC stock go up or go down?
Revance Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Revance Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Revance Therapeutics is overvalued.
Is Revance Therapeutics Stock a Buy?
- Revance Therapeutics share price is 5.85 while RVNC 8-day exponential moving average is 6.16, which is a Sell signal.
- The stock price of RVNC is 5.85 while Revance Therapeutics 20-day EMA is 6.17, which makes it a Sell.
- Revance Therapeutics 50-day exponential moving average is 5.44 while RVNC share price is 5.85, making it a Buy technically.
- RVNC stock price is 5.85 and Revance Therapeutics 200-day simple moving average is 6.58, creating a Sell signal.
Fundamental Analysis of Revance Therapeutics
Is Revance Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.54 per share, an increase next quarter of $0.40 per share, an increase this year of $2.64 per share, and an increase next year of $0.70 per share.
Technical Analysis of Revance Therapeutics
Should I short Revance Therapeutics stock?
- RVNC Moving Average Covergence Divergence (MACD) indicator is 0.2, suggesting Revance Therapeutics is a Buy
- Revance Therapeutics Relative Strength Index (RSI) is 44.27, which suggest Revance Therapeutics is oversold
- The Bollinger Bands (25) for Revance Therapeutics is (6.24 - 6.72), which suggest Revance Therapeutics is a Buy
- The Bollinger Bands (100) for Revance Therapeutics is (2.6 - 5.68), which suggest Revance Therapeutics is a Buy
* Revance Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.